Glucagon-like-peptide-2 (GLP-2) analogues

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9453064
SERIAL NO

14398297

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis, treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZEALAND PHARMA A/SSMEDELAND 36 GLOSTRUP DK-2600

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bovbjerg, Kirsten Lindegaard Hørsholm, DK 3 40
Just, Rasmus Copenhagen, DK 13 182
Riber, Ditte Brønshøj, DK 48 1015
Russell, Wayne Shaun Kävlinge, SE 4 40

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00